Form 4: Guardant Health Director Sells Shares in Open Market Transaction

Tariq Musa, a director at Guardant Health, sold 116 shares of common stock at a price of $34.85 per share on December 18, 2024.

Summary

• Tariq Musa, a director of Guardant Health, Inc., executed a sale of 116 shares of the company's common stock.
• The transaction occurred on December 18, 2024.
• The shares were sold at a price of $34.85 per share.
• Following the transaction, Mr. Musa directly owns 2,810 shares of Guardant Health common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing for a stock sale by a director. It doesn't indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine Form 4 filing, which is common for corporate insiders who trade company stock. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The sale of 116 shares by a director is a relatively small transaction and is not unusual.
• Similar filings are made by directors and officers of companies like Exact Sciences (EXAS) and Illumina (ILMN) when they trade their company's stock.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment, but is unlikely to have a significant effect on the company's operations or financial health.

Key Dates

Keywords

Guardant Health, Tariq Musa, stock sale, insider trading, Form 4, director